Similar articles for PMID: 29545594

Year	Number of Results
1993	2
1995	1
1996	3
1997	1
1998	5
1999	4
2000	5
2001	7
2002	1
2003	2
2004	3
2005	2
2007	4
2008	4
2009	3
2010	3
2011	1
2012	2
2013	5
2014	5
2015	5
2016	13
2017	12
2018	7
2019	5
2020	10
2021	4
2022	3
2023	3
2024	0

1

High transplant-related mortality associated with haematopoietic stem cell transplantation for paediatric therapy-related acute myeloid leukaemia (t-AML). A study on behalf of the United Kingdom Paediatric Blood and Bone Marrow Transplant Group.

Gassas A, Sivaprakasam P, Cummins M, Breslin P, Patrick K, Slatter M, Skinner R, Shenton G, Gibson B, Lawson S, Petterson T, Potter M, James B, Hough R, Hiwarkar P, Vora A, Veys P, De La Fuente J, Wynn R, Amrolia P. Gassas A, et al. Bone Marrow Transplant. 2018 Sep;53(9):1165-1169. doi: 10.1038/s41409-018-0157-x. Epub 2018 Mar 15. Bone Marrow Transplant. 2018. PMID: 29545594

2

Fludarabine, cytarabine, granulocyte colony-stimulating factor, and idarubicin (FLAG-IDA) for the treatment of children with poor-prognosis acute leukemia: the Hacettepe experience.

Tavil B, Aytac S, Balci YI, Unal S, Kuskonmaz B, Yetgin S, Gurgey A, Tuncer M, Gumruk F, Uckan D, Cetin M. Tavil B, et al. Pediatr Hematol Oncol. 2010 Oct;27(7):517-28. doi: 10.3109/08880018.2010.493578. Pediatr Hematol Oncol. 2010. PMID: 20677923

3

Fludarabine, cytarabine, granulocyte colony-stimulating factor and idarubicin for relapsed childhood acute myeloid leukemia.

Nakayama H, Tomizawa D, Tanaka S, Iwamoto S, Shimada A, Saito AM, Yamashita Y, Moritake H, Terui K, Taga T, Matsuo H, Kosaka Y, Koh K, Hosoi H, Kurosawa H, Isoyama K, Horibe K, Mizutani S, Adachi S. Nakayama H, et al. Pediatr Int. 2017 Oct;59(10):1046-1052. doi: 10.1111/ped.13378. Pediatr Int. 2017. PMID: 28771903 Clinical Trial.

4

Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.

Yalman N, Sarper N, Devecioğlu O, Anak S, Eryilmaz E, Can M, Yenilmez H, Ağaoğlu L, Gedikoğlu G. Yalman N, et al. Turk J Pediatr. 2000 Jul-Sep;42(3):198-204. Turk J Pediatr. 2000. PMID: 11105617 Clinical Trial.

5

A prognostic model for survival after salvage treatment with FLAG-Ida +/- gemtuzumab-ozogamicine in adult patients with refractory/relapsed acute myeloid leukaemia.

Bergua JM, Montesinos P, Martinez-Cuadrón D, Fernández-Abellán P, Serrano J, Sayas MJ, Prieto-Fernandez J, García R, García-Huerta AJ, Barrios M, Benavente C, Pérez-Encinas M, Simiele A, Rodríguez-Macias G, Herrera-Puente P, Rodríguez-Veiga R, Martínez-Sánchez MP, Amador-Barciela ML, Riaza-Grau R, Sanz MA; PETHEMA group. Bergua JM, et al. Br J Haematol. 2016 Sep;174(5):700-10. doi: 10.1111/bjh.14107. Epub 2016 Apr 26. Br J Haematol. 2016. PMID: 27118319 Free article.

6

FLAG-Ida Regimen as Bridge Therapy to Allotransplantation in Refractory/Relapsed Acute Myeloid Leukemia Patients.

Delia M, Pastore D, Carluccio P, Pasciolla C, Ricco A, Rossi AR, Casieri P, Mestice A, Albano F, Specchia G. Delia M, et al. Clin Lymphoma Myeloma Leuk. 2017 Nov;17(11):767-773. doi: 10.1016/j.clml.2017.06.002. Epub 2017 Jun 19. Clin Lymphoma Myeloma Leuk. 2017. PMID: 28864170

7

FLAG-idarubicin and allogeneic stem cell transplantation for Ph-positive ALL beyond first remission.

Deane M, Koh M, Foroni L, Galactowicz G, Hoffbrand AV, Lawler M, Secker-Walker L, Prentice HG. Deane M, et al. Bone Marrow Transplant. 1998 Dec;22(12):1137-43. doi: 10.1038/sj.bmt.1701521. Bone Marrow Transplant. 1998. PMID: 9894715

8

Treatment of relapse after allogeneic bone marrow transplantation with reduced intensity conditioning (FLAG +/- Ida) and second allogeneic stem cell transplant.

Pawson R, Potter MN, Theocharous P, Lawler M, Garg M, Yin JA, Rezvani K, Craddock C, Rassam S, Prentice HG. Pawson R, et al. Br J Haematol. 2001 Dec;115(3):622-9. doi: 10.1046/j.1365-2141.2001.03150.x. Br J Haematol. 2001. PMID: 11736947 Free article.

9

FLAG vs FLAG-IDA: outcomes in relapsed/refractory acute leukemias.

Farooq MU, Mushtaq F, Farooq A, Khan DH, Mir MA. Farooq MU, et al. Cancer Chemother Pharmacol. 2019 Jun;83(6):1191-1193. doi: 10.1007/s00280-019-03792-8. Epub 2019 Feb 13. Cancer Chemother Pharmacol. 2019. PMID: 30887181

10

FLAG-IDA in the treatment of refractory/relapsed acute leukaemias: single centre study.

Hashmi KU, Khan B, Ahmed P, Raza S, Hussain I, Mahmood A, Iqbal H, Malik HS, Anwar M. Hashmi KU, et al. J Pak Med Assoc. 2005 Jun;55(6):234-8. J Pak Med Assoc. 2005. PMID: 16045091

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

113 results

Results by year